Immunoprotective potential of polysaccharide-tetanus toxoid conjugate in Klebsiella pneumoniae induced lobar pneumonia in rats

Indian Journal of Experimental Biology

Volumn 43, Issue 1, 2005, Pages 40-45

  Chhibber, S ^a   Rani, Mamta ^a   Yadav, Vanashree ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Klebsiella pneumoniae Polysaccharide tetanus toxoid conjugate; Pneumonia

Indexed keywords

BACTERIOPHAGES; DERMATOLOGY; IMMUNOLOGY; POLYSACCHARIDES; PULMONARY DISEASES; SKIN;

KLEBSIELLA PNEUMONIAE; LIPOPOLYSACCHARIDES (LPS); MACROPHAGE ACTIVATION; SKIN REACTION;

BACTERIA;

BACTERIAL POLYSACCHARIDE; BACTERIAL VACCINE; TETANUS TOXOID; VACCINE;

ANIMAL; ARTICLE; BACTERIAL PNEUMONIA; DISEASE MODEL; ENTEROBACTER INFECTION; FEMALE; IMMUNOLOGY; KLEBSIELLA PNEUMONIAE; MOUSE; RABBIT; RAT; VACCINATION; WISTAR RAT;

ANIMALS; BACTERIAL VACCINES; DISEASE MODELS, ANIMAL; FEMALE; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICE; PNEUMONIA, BACTERIAL; POLYSACCHARIDES, BACTERIAL; RABBITS; RATS; RATS, WISTAR; TETANUS TOXOID; VACCINATION; VACCINES, CONJUGATE;

ANIMALIA; BACTERIA (MICROORGANISMS); KLEBSIELLA; KLEBSIELLA PNEUMONIAE; ORYCTOLAGUS CUNICULUS;

EID: 11444252740     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Podcshun R, Ullman U, Klebsiella spp as nosocomial pathogens: Epidemiology, taxonomy, typing methods and pathogenecity factors, Clin Microbiol Rev, 11 (1998) 589.
2. Cryz SJ Jr, Fuerer E & Germanier R, Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans, J Infect Dis, 151 (1985) 665.
3. Held TK, Jendrike NRM, Rukavina TAV, Podschun R & Trautmann M, Binding to and opsonophagocytic activity of O-antigen-specific monoclonal antibodies against encapsulated and non-encapsulated Klebsiella pneumoniae serotype O1 strains, Infect Immun, 68 (2000) 2402.
4. Chhibber S, Aggarwal S & Yadav V, Contribution of capsular and lipopolysaccharide antigens to the pathogenesis of Klebsiella pneumoniae respiratory tract infection, Folia Microbiol, 48 (2003) 669.
5. Rani M, Gupta RK & Chhibber S, Protection against Klebsiella aerogenes induced lobar pneumonia in rats with lipopolysaccharide and its related antigens, Can J Microbiol, 36 (1990) 885.
6. Chathley UC, Sharma S & Chhibber S, Lipopolysaccharide induced resistance in mice against ascending urinary tract infection with Klebsiella pneumoniae, Folia Microbiol, 41 (1996) 373.
7. Rietschel ET, Braude H, Wollenweber HW, Zaehringer U & Ludertiz O, Structural principles of endotoxically active lipid A's, EOS J Immunol Immunopharmacol, 6 (1986) 32.
8. Modsier DE & Subbarao B, Thymus independent antigens : complexity of B-lympohcyte activation revealed, Immunol Today, 3 (1982) 217.
9. Ada G & Isaacs D, Carbohydrate protein conjugate vaccines, Clin Microbiol Infect, 9 (2003) 79.
10. Cryz SJ Jr, Furer E, Sadoff JC & Germanier R, Pseudomonas aeruginosa immunotype 5 polysaccharide toxin A conjugate vaccines, Infect Immun, 52 (1986) 161.
11. Cryz SJ Jr, Sadoff JC, Furer E & Germanier R, Pseudomonas aeruginosa polysaccharide - tetanus toxoid conjugate vaccine: Safety and immunogenicity in humans, J Infect Dis, 154 (1986) 682.
12. Cryz SJ Jr, Sadoff JC & Fuerer E, Immunization with a Pseudomonas aeruginosa immunotype 5 O-polysaccharide-toxin A conjugate vaccine. Effect of a booster dose on antibody levels in humans, Infect Immun, 56 (1988) 1829.
13. Seid RC Jr & Sadoff JC, Preparation and characterization of detoxified lipopolysaccharide-protein conjugates, J Biol Chem, 256 (1981) 7305.
14. Westphal O & Jann K, Bacterial lipopolysaccharides : Extraction with phenol-water and further application of the procedures, in Methods in carbohydrate chemistry, edited by RL Whistler (Academic Press, New York) 1965, 83.
15. Morrison DC & Leive L, Fractions of lipopolysaccharide from Escherichia coli O111 : 84 prepared by two extraction procedures, J Biol Chem, 250 (1975) 2911.
16. Johnson KG & Perry M, Improved techniques for the preparation of bacterial lipopolysaccharides, Can J Microbiol, 22 (1976) 29.
17. Galanos C, Luederitz O & Westphal O, Preparation and properties of antisera against the lipid A component of bacterial lipopolysaccharide, Eur J Biochem, 24 (1971) 116.
18. Blumenkrantz N & Asboe-Hansen G. New method for quantitative determination of uronic acids. Anal Biochem, 54 (1973) 484.
19. Cryz SJ Jr, Sadoff JC, Fuerer E & Germanier R, Pseudomonas aeruginosa polysaccharide-tetanus toxoid conjugate vaccine : safety and immunogenicity in humans, J Infect Dis, 154 (1986) 682.
20. Dubois M, Gilles KA, Hamilton JK, Rebers PA & Smith F, Colorimeteric method for determination of sugars and related substances, Annal Chem, 28 (1956) 350.
21. Garner CV, Des JD & Pier GB, Immunogenic properties of Pseudomonas aeruginosa mucoid expolysaccharide, Infect Immun, 58 (1990) 1835.
22. Sugar AM, Bummer E & Sevens DA, Murine pulmonary macrophages: Evaluation of lung lavage fluids miniaturized monolayers and candidacidal activity, Am Rev Respir Dis, 127 (1983) 110.
23. Nishi T & Tsychiya K, Experimental urinary tract infection with Pseudomonas aeruginosa in mice, Infec Immun, 22 (1978) 508.
24. Bixler GS & Pillai S, The cellular basis of the immune response by conjugate vaccines, Contrib Microbiol Immunol, 10 (1989) 18.
25. Laferriere CA, Sood RK, deMuys JM, Michon F & Jennings HJ, The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenecity, Vaccine 15 (1997) 179.
26. Mehta ND, Wilson BM, Rapson NT & Easmon CSF, Comparison of the opsonic activity of polyclonal and monoclonal antibodies raised against Salmonella Minnesota strain R595, J Med Microbiol 25 (1988) 85.
27. Mehta ND, Wilson BM, Rapson NT & Easmon CSF, Comparison of specificity and biological activity of polyclonal and monoclonal antibodies raised against Salmonella Minnesota R595 lipopolysaccharide, J Med Microbiol, 31 (1990) 85.
28. Williams P, Lambert P, Haigh CG & Brown MRW, The influence of the O and K antigens of Klebsiella aerogenes on surface hydrophobicity and susceptibility to phagocytosis and antimicrobial agents, J Med Microbiol 21 (1986) 125.
29. Robert IS, Mountfor R, High N, Jann KB, Bitter SD, Timmis K & Boulnois G, Molecular cloning and analysis of genes for production of K5, K7, K12 & K92 capsular polysaccharides of Escherichia coli, J Bacteriol, 168 (1986) 1228.
30. Rauly IS, Goetsch L, Haeuw JF, Tardieux C, Baussant T, Bonnefoy JV & Corvaia, N, Carrier Properties of a Protein Derived from Outer Membrane Protein A of Klebsiella pneumoniae, Infection and Immunity, 67 (1999) 5547.